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ABSTRACT
Objectives: To understand the educational needs and
preferences of young clinicians and physician
researchers in the field of rheumatology in Europe.
Methods: An international online survey was
performed as a joint venture of ESCET and EMEUNET.
The survey assessed the acceptance of and the access
to the current European League Against Rheumatism
(EULAR) educational portfolio, as well as the unmet
educational needs and learning preferences among
individuals below the age of 40 years working in
rheumatology in Europe.
Results: Among 568 European clinicians and
physician researchers, 65% indicated that the existing
EULAR educational portfolio adequately covers their
educational needs. Within the EULAR portfolio, the
online course on rheumatic diseases and the
postgraduate course were the most appreciated.
Participants were very much in favour of new
educational courses on imaging techniques, and 63%
of participants indicated a particular interest in
musculoskeletal ultrasound. A strong interest in
refresher (60%) and general review (55%) courses was
observed. Lack of funding was considered the major
obstacle to participating in existing EULAR
programmes. Finally, participants showed diverse
preferences regarding learning modalities with
common interests in live courses and conferences.
Conclusions: EULAR’s training opportunities are well
appreciated among young clinicians and physician
researchers in rheumatology. The results from this
survey will help to develop EULAR’s future educational
portfolio.
INTRODUCTION
Diligent medical education and scientific
training in rheumatology enables young clini-
cians and physician researchers to provide
the highest standards of care and develop
new treatment strategies for patients with
rheumatic and musculoskeletal diseases.
Well-trained young individuals are essential
for the prosperity of the European rheumatol-
ogy community, prompting the European
League Against Rheumatism (EULAR) to
identify education and training as one of its
key strategic activities.1 In addition to country-
specific schedules that govern the educational
standards of young individuals,1–4 EULAR
offers courses and educational materials that
cover niches or complement national train-
ing programmes.1
Medical care in rheumatology is changing
rapidly, which creates new educational needs.
In addition, novel training technologies are
evolving quickly. Online courses and podcasts
Key messages
What is already known about this subject?
▸ Emerging EULAR network (EMEUNET) and
EULAR standing committee for education and
training (ESCET) conducted the first systematic
educational survey on the needs and preferences
of young individuals working in the field of
rheumatology in Europe.
What does this study add?
▸ Young clinicians and physician researchers
appreciated European League Against
Rheumatism (EULAR’s) current educational
portfolio.
▸ Participants were very much in favour of new
educational courses on imaging techniques, as
well as general review and refresher courses.
▸ Lack of funding was considered the major obs-
tacle to participating in existing EULAR
programmes.
How might this impact on clinical practice?
▸ The results from this survey will help to develop
EULAR’s future educational portfolio.
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can bring knowledge from world-leading experts to the
offices of young individuals worldwide. Almost 10 years
ago, EULAR launched the first online course on rheum-
atic diseases, which has become one of EULAR’s most
successful training programmes.1
The rapid changes in medical care and learning tech-
nologies prompted us to reach out to a large number of
young European physicians and scientists working in the
field of rheumatology to assess (1) the awareness and
acceptance of the current EULAR portfolio, (2) the
access to EULAR training opportunities and (3) the
unmet educational needs.
METHODS
Development and distribution of the survey
The survey was a joint venture of the EULAR standing
committee for education and training (ESCET) and the
Emerging EULAR network (EMEUNET). The
EMEUNETeducation subgroup piloted the survey, which
was reviewed by the EMEUNET working group and
ESCET. The final version of the survey was uploaded on
SurveyMonkey (complete survey available on request)
and email invitations were sent to all EMEUNET
members. In addition, EMEUNET country liaisons dis-
tributed invitations within national groups of young clini-
cians and researchers. After the initial invitation, three
reminders were sent using the same distribution strategy.
Individuals below the age of 40 years performing clinical
and/or scientific work in the field of rheumatology were
asked to participate. The intended time length of the
survey was a maximum of 15 min to ensure high partici-
pation and completion rates. The survey mainly assessed
categorical responses. At the end of each assessment (eg,
awareness of educational programmes or access to educa-
tional programmes), participants were invited to provide
additional open comments. Data were collected between
November 2013 and March 2014.
Data handling
For all participants, individual responses were checked
for completeness. If respondents did not fully answer
the questions on basic characteristics including demo-
graphics, work and research focus, they were excluded
from further analysis. For the specific assessments of
clinical or scientific educational needs, participants were
allowed to complete or skip the respective section in
order to avoid unnecessary questions.
All participants were categorised as ‘clinician’,
‘researcher’ or ‘physician researcher’, with the latter per-
forming both research and clinical work. Clinicians and
physician researchers were further categorised according
to: (1) clinical position and (2) country of origin, which
was further allocated to one of the three following
groups according to the gross domestic product (GDP)
per capita 20145 as follows: Group 1: Norway,
Switzerland, Denmark, Sweden, Ireland, the
Netherlands, Austria, Belgium, Germany, UK, France,
Italy, Andorra; Group 2: Spain, Cyprus, Malta, Slovenia,
Portugal, Greece, Estonia, Czech Republic, Slovakia,
Lithuania, Latvia, Poland, Hungary; Group 3: Croatia,
Russia, Turkey, Romania, Belarus, Azerbaijan, Bulgaria,
Serbia, Albania, Georgia, Ukraine, Moldova.
Statistical analysis
Of a total of 773 participants, 728 completed the ques-
tions on basic characteristics and were included in the
first analysis. Given the different background and educa-
tional needs, participants from outside Europe and
those whose work status was ‘researcher’ were then
excluded, resulting in a selection of young European
clinicians and physician researchers. Categorical vari-
ables were compared across groups with the χ2 test.
Continuous variables were compared across three
groups using one-way analysis of variance (ANOVA). For
all analyses, p values <0.05 were considered significant.
Statistical analysis was carried out using IBM SPSS
Statistics V.21 (IBM Deutschland GmbH, Ehningen,
Germany) and GraphPadPrism V.5.03 (GraphPad
Software, San Diego, California, USA). Open answers
and comments were not analysed systematically.
RESULTS
Characteristics of participants
Ninety per cent of all participants were from Europe
(N=656), with the highest number of respondents
coming from Spain (14%) and France (8%) (see online
supplementary table S1). We observed a female predom-
inance (68%), and most of the participants were
between 25 and 35 years (76%) of age (see online
supplementary table S2). Most participants’ work status
was ‘physician researcher’ (53%), defined as someone
who performs both clinical work and research, followed
by ‘clinician’ (34%) and ‘researcher’ (13%) (see online
supplementary table S2). In their clinical work, most
participants were trainees or young consultants in
rheumatology (90%). The majority of participants hold
a research position as a PhD candidate, postdoctoral or
junior researcher (86%), while only a few Master’s stu-
dents or senior researchers participated in the survey
(see online supplementary table S2). A total of 568 par-
ticipants were included in the detailed analysis after
excluding 72 participants from non-European countries
and 88 non-clinical scientists.
Regarding their daily schedule, clinicians spent 74
±18% of their time in clinical work. Physician research-
ers also spent most of their time in clinical work (59
±22%) while they used 23±20% of their time for
research (see online supplementary figure S1). Overall,
participants dedicated less time to teaching (14±13%)
and little time to administration (5±9%). While phys-
ician researchers performed clinical/epidemiological
(78%), basic (24%) and/or translational research
(17%), most clinicians (51%) did not carry out research.
Asked about their career plans, clinicians and physician
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researchers both showed the highest interest in pursuing
a clinical career, followed by an academic career or
career in private practice. Both clinicians and physician
researchers indicated little interest in working in indus-
try, independent from their clinical position (see online
supplementary table S4).
Awareness and access to existing educational
programmes
The general awareness of the existing educational pro-
grammes under the EULAR umbrella was high for the
well-established programmes, although the participation
rates were modest. Thirty-two per cent of all participants
had already participated in the EULAR online course on
rheumatic diseases and 13% in the EULAR postgraduate
course (table 1A). The participation rate in the EULAR
online course on rheumatic diseases was similar between
trainees in rheumatology and young consultants, the
most frequent clinical positions held by the survey parti-
cipants. In contrast, participation of young consultants
at the EULAR postgraduate course, a live course,
exceeded that of trainees in rheumatology (table 1B, C).
Table 1 Awareness of existing programmes
Characteristic
Clinicians and physician
researchers
Have
never
heard of
N (%)
Have
heard of
N (%)
Would like to
participate in
N (%)
Have strong
interest in
N (%)
Have
participated
in
N (%)
Σ
N (%)
χ2,
p value
(a) All participants
EULAR online course 55 (10) 78 (14) 112 (21) 125 (23) 174 (32) 544 (100) NA
EULAR online course on
Connective Tissue Diseases
79 (15) 146 (27) 146 (27) 155 (29) 18 (3)
EULAR/EUSTAR online course
on SSc
87 (16) 161 (30) 146 (27) 122 (22) 28 (5)
EULAR ultrasound online course 93 (17) 134 (25) 117 (22) 152 (28) 48 (9)
EULAR postgraduate course 118 (22) 125 (23) 107 (20) 121 (22) 73 (13)
EULAR epidemiology course 141 (26) 178 (33) 110 (20) 84 (15) 31 (6)
ACR/EULAR exchange
programme
208 (38) 142 (26) 89 (16) 98 (18) 7 (1)
EUREKA course of Translational
Medicine
277 (51) 130 (24) 83 (15) 46 (9) 8 (2)
EUSTAR SSc course 187 (34) 139 (26) 92 (17) 98 (18) 28 (5)
EULAR course on capillaroscopy 127 (23) 159 (29) 114 (21) 121 (22) 23 (4)
EULAR ultrasound course 78 (14) 112 (21) 107 (20) 197 (36) 50 (9)
(b) EULAR online course—clinical position
Medical student 3 (38) 2 (25) 3 (38) 0 (0) 0 (0) 8 (100) <0.001
Trainee (internal m.) 6 (14) 9 (21) 11 (25) 9 (21) 9 (21) 44 (100)
Trainee (rheum.) 32 (11) 34 (11) 54 (18) 79 (26) 102 (34) 301 (100)
Young consultant 14 (7) 33 (17) 44 (23) 37 (19) 63 (33) 191 (100)
(c) EULAR postgraduate course—clinical position
Medical student 4 (50) 4 (50) 0 (0) 0 (0) 0 (0) 8 (100) <0.001
Trainee (internal m.) 20 (45) 7 (16) 9 (20) 5 (11) 3 (7) 44 (100)
Trainee (rheum.) 74 (25) 65 (22) 60 (20) 73 (24) 29 (10) 301 (100)
Young consultant 20 (11) 49 (26) 38 (20) 43 (23) 41 (22) 191 (100)
(d) EULAR online course—country of origin
Group 1 27 (12) 40 (18) 50 (23) 40 (19) 65 (29) 222 (100) 0.118
Group 2 23 (10) 31 (14) 45 (20) 56 (25) 74 (32) 229 (100)
Group 3 4 (4) 7 (8) 17 (19) 29 (32) 35 (38) 92 (100)
(e) EULAR postgraduate course—country of origin
Group 1 79 (35) 59 (27) 33 (15) 39 (18) 12 (5) 222 (100) <0.001
Group 2 32 (14) 53 (23) 51 (22) 54 (24) 39 (17) 229 (100)
Group 3 7 (8) 12 (13) 23 (25) 28 (30) 22 (24) 92 (100)
(a–e) Total sample with N=656 participants of whom 544 responded to this part of the survey. Values are expressed as absolute numbers and
percentages in brackets as N (%).
(a) Analysis with all responses. (b, c) Analysis on categorisation of participants according to clinical position. (d, e) Analysis on categorisation
of participants according to country of origin. Countries allocated to groups 1–3 according to the GDP per capita 2014. Group 1: Norway,
Switzerland, Denmark, Sweden, Ireland, the Netherlands, Austria, Belgium, Germany, UK, France, Italy, Andorra; Group 2: Spain, Cyprus,
Malta, Slovenia, Portugal, Greece, Estonia, Czech Republic, Slovakia, Lithuania, Latvia, Poland, Hungary; Group 3: Croatia, Russia, Turkey,
Romania, Belarus, Azerbaijan, Bulgaria, Serbia, Albania, Georgia, Ukraine, Moldova.
ACR, American College of Rheumatology; EULAR, European League Against Rheumatism; EUSTAR, European Scleroderma Trial and
Research Organization; GDP, gross domestic product; internal m, internal medicine; NA, not applicable; rheum, rheumatism; SSc, systemic
sclerosis.
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Of note, participation rates in the EULAR online course
on rheumatic diseases and the EULAR postgraduate
course were higher among young individuals from coun-
tries with a lower GDP (group 3; table 1D, E). This
trend was reversed, however, for the more competitive
programmes, such as the ACR/EULAR exchange pro-
gramme and the EUREKA course of Translational
medicine, although the very low numbers of participants
in these training opportunities do not allow one to draw
final conclusions (see online supplementary figure S9).
The current EULAR educational programme was very
well received by the survey participants: a majority of
64% disagreed with the statement that the EULAR edu-
cational programme did not cover their needs, while
Table 2 Access to existing programmes
Characteristic
Clinicians and physician researchers
Fully
agree
N (%)
Mostly
agree
N (%)
Partially
agree
N (%)
Do not
agree
N (%)
Undecided
N (%)
Σ
N (%)
χ2,
p value
(a) All participants
I do not have enough and timely
information about ongoing projects
61 (11) 116 (22) 187 (35.1) 144 (27.0) 25 (5) 533 (100) NA
I cannot afford my educational needs on
my own
157 (30) 151 (28) 130 (24) 75 (14) 20 (4)
My department does not provide me
enough leave to participate in
69 (13) 100 (19) 169 (32) 178 (33) 17 (32)
I do not have access to departmental/
institutional funding
105 (20) 135 (25) 151 (28) 114 (21) 28 (5)
I do not have access to alternative means
of funding
74 (14) 132 (25) 176 (33) 127 (24) 24 (5)
The current EULAR educational
programme does not cover my
educational needs
14 (3) 25 (4.7) 88 (17) 341 (64) 65 (12)
(b) I do not have enough and timely information about ongoing projects—clinical position
Medical student 1 (17) 1 (17) 1 (17) 3 (50) 0 (0) 6 (100) <0.001
Trainee (internal m.) 7 (16) 10 (23) 15 (35) 9 (21) 2 (5) 43 (100)
Trainee (rheum.) 39 (13) 68 (23) 107 (36) 67 (23) 16 (5) 297 (100)
Young consultant 15 (8) 37 (20) 64 (34) 67 (36) 4 (2) 187 (100)
(c) I cannot afford my educational needs on my own—clinical position
Medical student 1 (17) 1 (17) 2 (33) 0 (0) 2 (33) 6 (100) <0.001
Trainee (internal m.) 11 (26) 14 (33) 12 (28) 2 (5) 4 (9) 43 (100)
Trainee (rheum.) 93 (30) 84 (27) 70 (22) 42 (14) 8 (3) 297 (100)
Young consultant 52 (28) 52 (28) 46 (25) 31 (17) 6 (3) 187 (100)
(d) The current EULAR educational programme does not cover my educational needs—clinical position
Medical student 0 (0) 1 (17) 1 (17) 1 (17) 3 (50) 6 (100) <0.001
Trainee (internal m.) 0 (0) 3 (7) 5 (12) 27 (63) 8 (19) 43 (100)
Trainee (rheum.) 10 (3) 16 (5) 52 (18) 181 (61) 38 (13) 297 (100)
Young consultant 4 (2) 5 (3) 30 (16) 132 (71) 16 (9) 187 (100)
(e) I do not have enough and timely information about ongoing projects—country of origin
Group 1 22 (10) 52 (24) 81 (38) 49 (23) 12 (6) 216 (100) 0.525
Group 2 29 (13) 47 (21) 77 (34) 61 (27) 11 (5) 225 (100)
Group 3 10 (11) 17 (19) 29 (32) 34 (37) 2 (2) 92 (100)
(f) I cannot afford my educational needs on my own—country of origin
Group 1 37 (17) 71 (33) 61 (28) 36 (17) 11 (5) 216 (100) 0.525
Group 2 72 (32) 65 (29) 52 (23) 28 (12) 8 (4) 225 (100)
Group 3 48 (52) 15 (16) 17 (19) 11 (12) 1 (1) 92 (100)
(g) The current EULAR educational programme does not cover my educational needs—country of origin
Group 1 4 (2) 10 (5) 36 (17) 132 (61) 34 (16) 216 (100) 0.690
Group 2 6 (3) 11 (5) 32 (14) 153 (68) 23 (10) 225 (100)
Group 3 4 (4) 4 (4) 20 (22) 56 (61) 8 (9) 92 (100)
(a–g) Total sample with N=656 participants of whom 533 responded to this part of the survey. Values are expressed as absolute numbers and
percentages in brackets as N (%).
(a) Analysis with all responses. (b–d) Analysis on categorisation of participants according to clinical position. (e–g) Analysis on categorisation
of participants according to country of origin. Countries allocated to groups 1–3 according to the GDP per capita 2014. Group 1: Norway,
Switzerland, Denmark, Sweden, Ireland, The Netherlands, Austria, Belgium, Germany, UK, France, Italy, Andorra; Group 2: Spain, Cyprus,
Malta, Slovenia, Portugal, Greece, Estonia, Czech Republic, Slovakia, Lithuania, Latvia, Poland, Hungary; Group 3: Croatia, Russia, Turkey,
Romania, Belarus, Azerbaijan, Bulgaria, Serbia, Albania, Georgia, Ukraine, Moldova.
EULAR, European League Against Rheumatism; GDP, gross domestic product; NA, not applicable.
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only 3% were in full agreement (table 2A). Acceptance
rates were even higher among young consultants with
up to 71% disagreeing with the aforementioned state-
ment (table 2D). Lack of funding opportunities was con-
sidered the predominant obstacle to participation: 58%
of participants fully or mostly agreed that they cannot
afford their educational needs on their own. In addition,
45% fully or mostly agreed that they do not have access
to institutional funding, and 39% that they do not have
enough alternative means of funding (table 2A). In this
regard, trainees in internal medicine, trainees in
rheumatology and young consultants indicated a similar
lack of funding for their educational needs (table 2C).
As expected, individuals from countries with a lower
GDP more frequently experienced problems with course
funding (table 2F). Finally, participants considered lack
of timely information about ongoing educational oppor-
tunities and lack of leave from work as minor obstacles
to participating in the EULAR educational programme
(table 2A–G).
Interests and needs of participants
When asked about their needs and interests, participants
were allowed to skip the clinical or scientific assessment.
Nevertheless, clinicians and physician researchers
showed high interest in clinical (91%) and scientific
(81%) educational programmes (data not shown).
Regarding dedicated clinical courses, the majority of
participants indicated interest or strong interest in
imaging studies, including X-ray (90%), ultrasound
(88%) and MRI (87%), as well as for refresher courses
(97%) and general review (95%) (table 3). When asked
about scientific training, responses from the participants
were more diverse: interest or strong interest was
expressed particularly for courses on statistics (85%),
research methodology (83%) and presentation skills
(80%) (table 3).
Finally, we observed a diversity of individual prefer-
ences when interviewing participants for their preferred
learning modalities. Interests in attending live courses
and conferences for learning purposes were higher com-
pared to other learning modalities (see online
supplementary table S5). Eighty-five per cent of partici-
pants preferred or strongly preferred participation in
live courses and 84% case-oriented and problem-
oriented learning.
DISCUSSION
The current survey assessed the educational needs of
young individuals in rheumatology to define and foster
future educational opportunities. The survey stands out
for its large sample size with around 600 participants
Table 3 Interests in specific training programmes
Characteristic
Clinicians and physician researchers
No interest
N (%)
Little interest
N (%)
Interested in
N (%)
Strong interest
N (%)
Σ
N (%)
(a) Clinical training programmes
Specific techniques
Communication skills 59 (12) 135 (28) 187 (39) 96 (20) 477 (100)
Clinical examination 22 (4) 54 (11) 197 (41) 204 (43)
Capillaroscopy 42 (9) 115 (24) 175 (37) 145 (30)
Arthrocentesis 38 (8) 83 (17) 166 (35) 190 (40)
Synovial fluid analysis 30 (6) 96 (20) 205 (43) 146 (30)
Urine analysis 107 (22) 185 (39) 129 (27) 56 (12)
Ultrasound 13 (3) 45 (9) 120 (25) 299 (63)
X-ray evaluation 10 (2) 40 (8) 193 (41) 234 (49)
MRI 11 (2) 48 (10) 202 (42) 216 (45)
Laboratory evaluations 29 (6) 79 (17) 194 (41) 175 (37)
Biopsy 42 (2) 101 (21) 169 (35) 165 (35)
General courses
Review courses on rheumatic diseases 5 (1) 19 (4) 190 (40) 263 (55)
Refreshers/updates 5 (1) 8 (2) 176 (37) 288 (60)
(b) Scientific training programmes
General background 10 (2) 69 (16) 220 (52) 122 (29) 421 (100)
Experimental techniques 36 (6) 117 (28) 183 (44) 109 (20)
Research methodology (epidemiology, etc) 15 (4) 59 (14) 197 (47) 150(36)
Writing skills 17 (4) 67 (16) 199 (47) 138 (33)
Reviewing skills 19 (5) 59 (14) 201 (48) 142 (34)
Presentation skills 18 (4) 68 (16) 172 (41) 163 (39)
Statistics (theory and practice) 12 (3) 50 (12) 170 (40) 189 (45)
Researchers were allowed to participate in or skip the assessment on clinical training programmes; clinicians were allowed to participate in or
skip the assessment on scientific training programmes. Upper part: All participants interested in clinical training programmes (N=477)
responded to the assessment. Lower part: All participants interested in scientific training programmes (N=421) responded to the assessment.
Values are expressed as total numbers and percentages in brackets as N (%).
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from 38 European countries. We addressed a broad
spectrum of educational details and obtained the follow-
ing key findings:
1. The current educational portfolio of EULAR is well
perceived among young individuals in the field,
which is in line with results from a small previous
study.3 Bandinelli et al3 observed a very high accept-
ance rate for the EULAR online course on rheumatic
diseases among 170 young rheumatologists across
Europe. Together, these findings reinforce EULAR’s
educational policy.
2. Lack of financial means is the major obstacle prevent-
ing participation in existing EULAR educational pro-
grammes. As expected, lack of funding opportunities
is a greater issue in countries with a lower GDP per
capita. Along with our findings, Gaujoux-Viala et al6
revealed financial support by bursaries as one of the
most important needs of 243 young rheumatologists.
To compensate for these financial needs, EULAR has
reduced the costs for the online courses and offers
course bursaries for its live courses. Future funding
opportunities might include educational funds from
government or industry.
3. The outstanding interest in imaging modalities (ultra-
sound, X-ray, MRI) may prompt EULAR to expand
its imaging educational programme even beyond the
ultrasound courses. EULAR’s future scientific courses
might teach statistics, presentation skills and research
methodologies, as these were among the main inter-
ests of young rheumatologists and researchers.
4. While learning preferences were diverse, live courses
and live conferences were very much favoured by our
participants. This piece of information may raise
EULAR’s awareness of ‘classical’ live teaching pro-
grammes, which may not always be replaceable by
online teaching opportunities.
5. The survey participants showed a strong interest in
pursuing a career in academia and in clinical envir-
onments, suggesting that EULAR invests in those
young individuals who will represent EULAR and the
European rheumatology community in future.
Our survey was subject to structural limitations: First,
the proportion of (non-physician) researchers was very
small within the study, reflecting that EMEUNET and
EULAR mainly represent physicians and physician
researchers and compelling us to exclude those indivi-
duals for the detailed analyses of this survey. Second,
EMEUNET members or individuals linked to the
EMEUNET network were more likely to receive invita-
tions and participate in the survey, with 46% of partici-
pants being indeed a member of EMEUNET. This might
result in a predominance of academia-oriented respon-
ders. Second, using the EMEUNET network to distribute
invitations to participate in the survey, we could not
determine the number of individuals who had finally
received our invitations. Finally, country-specific
response rates depended on pre-existing networks for
young rheumatologists that helped to invite participants.
Although the use of the EMEUNET network resulted in
many limitations of our study, we had already learnt in
an earlier study4 that this network was the only available
approach to reach out to young individuals all over
Europe: In a lot of European countries, national associa-
tions for medicine and rheumatology could provide
neither educational information nor contact details of
young individuals working in the field. In this context,
we wish that this survey may pioneer future educational
studies, which will exceed our current work in complete-
ness and unbiasedness of data by collecting information
from nationally registered young individuals in training
for rheumatology.
Taken together, this large survey among around 600
young individuals working in the field of rheumatology
reveals a high acceptance rate of the current EULAR
educational portfolio. Training on novel imaging tech-
nologies is among the most important educational
needs of these young individuals and cost-effective edu-
cational opportunities as well as live courses are much
appreciated.
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